59572-0775 Reblozyl - CanMED: NDC

Product NDC:

59572-0775

Brand Name:

Reblozyl

Generic Name:

Luspatercept

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Subcutaneous

Substances:

Name: LUSPATERCEPT

Strength: 75.0

Unit: mg/1

Packages:

Code: 59572-0775-01

Description: 1 VIAL, GLASS in 1 CARTON (59572-775-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

Effective Date: Nov. 8, 2019

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Erythropoiesis-Stimulating Agent

Minor Class:

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox